INVAInnoviva, Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $21.20 · now $21.20 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, INVA has typically landed between $18.98 and $24.29 — a range of −10.5% to +14.6% from the issuance price $21.20.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($21.20) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where INVA has typically landed a month from the 2026-09-16 close of $21.2 — the range is history, not a prediction.

$18.98worst · -10.5%$24.29best · +14.6%
  • now $21.2 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $21.26 (+0.3%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $20.14$22.39
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $18.98$24.29
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2015-08-28−49.2%−49.2%+15.7%
2008-09-26−48.3%−48.3%+0.0%
2008-09-29−47.9%−47.9%+0.0%
3 best
2008-11-24+105.0%+0.0%+105.0%
2008-11-21+103.0%+0.0%+103.0%
2008-12-02+102.3%+0.0%+102.3%

5,003 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
45%
−3.2%
n=20
Feb
50%
+4.3%
n=20
Mar
60%
+0.6%
n=20
Apr
50%
+4.0%
n=20
May
60%
+0.6%
n=20
Jun
50%
+1.1%
n=20
Jul
55%
+2.1%
n=20
Aug
40%
−2.7%
n=20
Sep
40%
−2.3%
n=20
Oct
45%
−1.5%
n=20
Nov
50%
+4.7%
n=20
Dec
50%
+4.7%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$24$17↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2025-03-06DENNER ALEXANDER JdirectorSale1,196,746 @ $17.52$21.0M−17.5% of holding+12.2%+2.7%5,658,705Form 4 · filed same day
2025-03-05DENNER ALEXANDER JdirectorSale270,374 @ $17.63$4.8M−3.8% of holding+10.3%+6.8%6,855,451Form 4 · filed 1 day after the trade
2025-03-04DENNER ALEXANDER JdirectorSale151,175 @ $17.63$2.7M−2.1% of holding+4.7%+6.7%7,125,825Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

56 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-20Raifeld PaveldirectorWithheld for tax1,130284,799Form 4
2026-08-20Zhen MarianneofficerWithheld for tax1,12756,389Form 4
2026-08-20Basso StephenofficerWithheld for tax55888,013Form 4
2026-05-20Raifeld PaveldirectorWithheld for tax1,130285,929Form 4
2026-05-20Zhen MarianneofficerWithheld for tax1,12757,516Form 4
2026-05-20Basso StephenofficerWithheld for tax55988,571Form 4
2026-05-18Linden JosephinedirectorAward / grant9,1669,166Form 4
2026-05-18Linden JosephinedirectorAward / grant9,46115,194Form 4
2026-05-18Linden JosephinedirectorAward / grant5,7335,733Form 4
2026-05-15Basso StephenofficerAward / grant1,12389,130Form 4
2026-05-15Raifeld PaveldirectorAward / grant1,123287,059Form 4
2026-05-04Small Derek AdirectorAward / grant10,00010,000Form 4
2026-05-04Zhen MarianneofficerAward / grant12,76658,643Form 4
2026-05-04Zhen MarianneofficerAward / grant31,50031,500Form 4
2026-05-04Haimovitz JulesdirectorAward / grant10,00010,000Form 4
2026-05-04DiPaolo MarkdirectorAward / grant10,00010,000Form 4
2026-05-04Raifeld PaveldirectorAward / grant126,646285,936Form 4
2026-05-04Raifeld PaveldirectorAward / grant312,500312,500Form 4
2026-05-04Schlesinger Sarah J.directorAward / grant9,786140,492Form 4
2026-05-04Schlesinger Sarah J.directorAward / grant10,00010,000Form 4
2026-05-04Basso StephenofficerAward / grant37,99488,007Form 4
2026-05-04Basso StephenofficerAward / grant93,75093,750Form 4
2026-05-04Haimovitz JulesdirectorAward / grant9,786152,692Form 4
2026-05-04DiPaolo MarkdirectorAward / grant9,786140,492Form 4
2026-05-04Small Derek AdirectorAward / grant9,78645,035Form 4
2026-02-20Raifeld PaveldirectorWithheld for tax2,986159,290Form 4
2026-02-20Zhen MarianneofficerWithheld for tax2,46045,877Form 4
2026-02-20Basso StephenofficerWithheld for tax1,24450,013Form 4
2025-11-20Zhen MarianneofficerWithheld for tax99248,337Form 4
2025-11-20Basso StephenofficerWithheld for tax23751,257Form 4
2025-11-15Basso StephenofficerAward / grant60451,494Form 4
2025-11-03Raifeld PaveldirectorAward / grant110,436162,276Form 4
2025-11-03Basso StephenofficerAward / grant27,60950,890Form 4
2025-08-20Zhen MarianneofficerWithheld for tax99149,329Form 4
2025-08-20Basso StephenofficerWithheld for tax23723,281Form 4
2025-05-20Zhen MarianneofficerWithheld for tax99250,320Form 4
2025-05-20Basso StephenofficerWithheld for tax23723,518Form 4
2025-05-19Haimovitz JulesdirectorAward / grant10,00010,000Form 4
2025-05-19Schlesinger Sarah J.directorAward / grant12,077130,706Form 4
2025-05-19Schlesinger Sarah J.directorAward / grant10,00010,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.